DUSA Pharmaceuticals, Inc.® To Host First Quarter 2011 Corporate Highlights And Financial Results Webcast And Conference Call
DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA) announces that its first quarter 2011 corporate highlights and financial results press release will be issued on Thursday, May 5 th at 6:30 a.m. to be followed by a conference call and audio webcast at 8:30 a.m. Conference call dial in and webcast log in details are as follows:
Thursday, May 5 th - 8:30 a.m. E.D.T.North American callers dial:877-645-6210International callers dial:970-315-0447Participant Conference ID: 63830923
A telephone replay will be available shortly after the live call concludes. To access the replay, dial 800-642-1687 (North American callers) or 706-645-9291 (International callers). The telephone replay and webcast will also be accessible on the investors section of our website approximately six hours following the call at www.dusapharma.com.About DUSA Pharmaceuticals DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan ® PDT technology platform, and other dermatology products. Levulan ® Kerastick ® for topical solution plus DUSA’s BLU-U ® blue light photodynamic therapy illuminator is currently approved for the treatment of minimally to moderately thick actinic keratoses (AKs) of the face or scalp. DUSA also markets other dermatology products, including ClindaReach ®. DUSA is based in Wilmington, Mass. Please visit our website at www.dusapharma.com.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV